<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37773124</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Randomised controlled trial testing effectiveness of feedback about lung age or exhaled CO combined with very brief advice for smoking cessation compared to very brief advice alone in North Macedonia:&#xa0;findings from the Breathe Well group.</ArticleTitle><Pagination><StartPage>1887</StartPage><MedlinePgn>1887</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1887</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-023-16644-1</ELocationID><Abstract><AbstractText Label="INTRODUCTION">In 2019, smoking prevalence in North Macedonia was one of the world's highest at around 46% in adults. However, access to smoking cessation treatment is limited and no co-ordinated smoking cessation programmes are provided in primary care.</AbstractText><AbstractText Label="METHODS">We conducted a three parallel-armed randomised controlled trial (n&#x2009;=&#x2009;1368) to investigate effectiveness and cost-effectiveness of lung age (LA) or exhaled carbon monoxide (CO) feedback combined with very brief advice (VBA) to prompt smoking cessation compared with VBA alone, delivered by GPs in primary care in North Macedonia. All participants who decided to attempt to quit smoking were advised about accessing smoking cessation medications and were also offered behavioural support as part of the "ACT" component of VBA. Participants were aged&#x2009;&#x2265;&#x2009;35&#xa0;years, smoked&#x2009;&#x2265;&#x2009;10 cigarettes per day, were recruited from 31 GP practices regardless of motivation to quit and were randomised (1:1:1) using a sequence generated before the start of recruitment. The primary outcome was biochemically validated 7-day point prevalence abstinence at 4&#xa0;weeks (wks). Participants and GPs were not blinded to allocation after randomisation, however outcome assessors were blind to treatment allocation.</AbstractText><AbstractText Label="RESULTS">There was no evidence of a difference in biochemically confirmed quitting between intervention and control at 4wks (VBA&#x2009;+&#x2009;LA RR 0.90 (97.5%CI: 0.35, 2.27); VBA&#x2009;+&#x2009;CO RR 1.04 (97.5%CI: 0.44, 2.44)), however the absolute number of quitters was small (VBA&#x2009;+&#x2009;LA 1.6%, VBA&#x2009;+&#x2009;CO 1.8%, VBA 1.8%). A similar lack of effect was observed at 12 and 26wks, apart from in the VBA&#x2009;+&#x2009;LA arm where the point estimate was significant but the confidence intervals were very wide. In both treatment arms, a larger proportion reported a reduction in cigarettes smoked per day at 4wks (VBA&#x2009;+&#x2009;LA 1.30 (1.10, 1.54); VBA&#x2009;+&#x2009;CO 1.23 (1.03, 1.49)) compared with VBA. The point estimates indicated a similar direction of effect at 12wks and 26wks, but differences were not statistically significant. Quantitative process measures indicated high fidelity to the intervention delivery protocols, but low uptake of behavioural and pharmacological support. VBA was the dominant intervention in the health economic analyses.</AbstractText><AbstractText Label="CONCLUSION">Overall, there was no evidence that adding LA or CO to VBA increased quit rates. However, a small effect cannot be ruled out as the proportion quitting was low and therefore estimates were imprecise. There was some evidence that participants in the intervention arms were more likely to reduce the amount smoked, at least in the short term. More research is needed to find effective ways to support quitting in settings like North Macedonia where a strong smoking culture persists.</AbstractText><AbstractText Label="TRIAL REGISTRATION">The trial was registered at http://www.isrctn.com (ISRCTN54228638) on the 07/09/2018.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gjorgjievski</LastName><ForeName>Dragan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Family Medicine, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stavrikj</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for Family Medicine, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. r.e.jordan@bham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adab</LastName><ForeName>Peymane</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanoevski</LastName><ForeName>Gjorgji</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Family Medicine, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stamenova</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Family Medicine, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krstevska</LastName><ForeName>Emilija</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Family Medicine, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonovska</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Family Medicine, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trpcheski</LastName><ForeName>Fillip</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre for Family Medicine, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Health Services Management Centre, School of Social Policy, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Easter</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rai</LastName><ForeName>Kiran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Kar Keung</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of General Practice, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Brendan G</ForeName><Initials>BG</Initials><AffiliationInfo><Affiliation>Lung Function &amp; Sleep, Queen Elizabeth Hospital, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Correia-de-Sousa</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickens</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Observational and Pragmatic research Institute, Midview City, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enocson</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gale</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Health Services Management Centre, School of Social Policy, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jolly</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jowett</LastName><ForeName>Sue</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maglakelidze</LastName><ForeName>Mariam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Petre Shotadze Tbilisi Medical Academy, 51/2 Ketevan Dedofali Ave, Tbilisi, 0144, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maghlakelidze</LastName><ForeName>Tamaz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Ivane Javakhishvili Tbilisi State University, 1 Ilia Chavchavadze Avenue, Tbilisi, 0179, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Family Medicine, ABC Medical School, Sao Paolo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sitch</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stelmach</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Si&#xe2;n</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>International Primary Care Respiratory Group, 19 Armour Mews, Larbert, FK5 4FF, Scotland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farley</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ISRCTN</DataBankName><AccessionNumberList><AccessionNumber>ISRCTN54228638</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>16/137/95</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016540" MajorTopicYN="Y">Smoking Cessation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003419" MajorTopicYN="N">Crisis Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005246" MajorTopicYN="N">Feedback</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018843" MajorTopicYN="N" Type="Geographic">Republic of North Macedonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014026" MajorTopicYN="N">Nicotiana</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carbon monoxide</Keyword><Keyword MajorTopicYN="N">LMIC</Keyword><Keyword MajorTopicYN="N">Lung age</Keyword><Keyword MajorTopicYN="N">RCT</Keyword><Keyword MajorTopicYN="N">Smoking cessation</Keyword><Keyword MajorTopicYN="N">Very brief advice</Keyword></KeywordList><CoiStatement>P Adab declares grant funding paid to her institution from NIHR, MRC and Colt Foundation, funding to Institution and to cover expenses as Chair of NIHR Public Health Research Funding Committee, Deputy Director of NIHR School for Public Health Research, funding to cover expense as Member of Wellcome Trust Early Career Advisory Group in Population and Public Health, Output Assessor for Panel A, subpanel 2 in 2021 Research Excellence Framework, and unfunded contributions as Chair for several NIHR funded TSCs, Member of the MRC funded Natural Experiments Evaluations Project Oversight Group, Member of Obesity Health Alliance Independent Obesity Strategy Working Group, Member of NIHR palliative and End of Life Care Research Partnerships call Panel, NIHR/UKRI Long COVID funding call Panel, NIHR COVID-19 Recovery and Learning Funding Committee; J Correia-De-Sousa declares grant funding to his institution from AstraZeneca and GSK, advisory board and consulting fees paid to himself from Boheringer Ingelheim, GSK, AstraZeneca, Bial, Medinfar, Payment for lectures from GSK, AstraZeneca and Sanofi Pasteur, support for attending meetings from Mundipharma and Mylan, leadership role for International Primary Care Respiratory Group (IPCRG); A Farley declares grant funding paid to her institution from NIHR GHR for the present manuscript, grant funding from NIHR HTA, NIHR EME, MRC and Ethicon (Johnson and Johnson) for other work, membership on DMEC for NIHR funded e-cigarette trial (no honorarium), leadership role for International Primary Care Respiratory Group (IPCRG); K Jolly declares grant funding paid to her institution from NIHR and MRC, participant in Data Safety Monitoring Board or advisory board for NIHR funded studies (no honorarium), Sub-committee chair of NIHR Programme Grants for Applied Health Research (payments to institution); R Jordan declares grant funding to her institution from NIHR, membership of Boehringer Ingelheim Primary Care Advisory Board, leadership role for International Primary Care Respiratory Group (IPCRG) &#x2013; research sub-committee; S M Martins declares leadership or fiduciary role in Brazilian Society of Medicine and Family and Community; ABC School of Medicine, GEPRAPS ( respiratory group of study and research in primay care), IPCRG (Internacional Primary Care Respiratory Group); A Sitch declares grant funding to her institution from NIHR GHR for present manuscript, NIHR Birmingham BRC and AstraZeneca; A Turner declares grant funding to her institution from NIHR GHR for present manuscript, grant funding from AstraZeneca and Chiesi for other work, payment of honoraria from GSK and Boehringer, support for attending meetings and/or travel from AstraZeneca and Chiesi; S Williams declares grants from the University of Birmingham paid to her institution; K K Cheng, A Dickens, N Gale, S Jowett R declare grant funding to their institution from NIHR GHR for current manuscript; Adams, C Chi, B Cooper, C Easter, A Enocson, D Gjorgjievski, E Krstevsha, T Maghlakelidze, M Maglakelidze, K Rai; A Stamenova, G Stanoevski, S Simonovska, K Stavrikj, R Stelmach, F Trpcheski have no conflicts to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37773124</ArticleId><ArticleId IdType="pmc">PMC10541684</ArticleId><ArticleId IdType="doi">10.1186/s12889-023-16644-1</ArticleId><ArticleId IdType="pii">10.1186/s12889-023-16644-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990&#x2013;2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet. 2021;Published online May 27, 2021. 10.1016/S0140-6736(21)01169-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8223261</ArticleId><ArticleId IdType="pubmed">34051883</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation. WHO report on the global tobacco epidemic 2019: Offer help to quit tobacco use. Powered by the California Digital Library; 2019. https://www.who.int/teams/health-promotion/tobacco-control/who-report-on-the-global-tobacco-epidemic-2019.</Citation></Reference><Reference><Citation>Stead L, Koilpillai P, Fanshawe T, et al. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:CD008286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10042551</ArticleId><ArticleId IdType="pubmed">27009521</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrott S, Godfrey C, Raw M, et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Thorax. 1998;53(2):Suppl 5: S2&#x2013;S3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1765918</ArticleId><ArticleId IdType="pubmed">10226676</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahab L. Cost-effectiveness of pharmacotherapy for smoking cessation. National Centre for Smoking Cessation Training - Briefing 7; 2012. https://www.ncsct.co.uk/usr/pub/B7_Cost-effectiveness_pharmacotherapy.pdf.</Citation></Reference><Reference><Citation>World Health Organisation. Who report on the global tobacco epidemic, 2019. 2019. https://www.who.int/teams/health-promotion/tobacco-control/who-report-on-the-global-tobacco-epidemic-2019.</Citation></Reference><Reference><Citation>West R, Stapleton J. Clinical and public health significance of treatments to aid smoking cessation. Eur Respir Rev. 2008;17(110):199&#x2013;204. doi: 10.1183/09059180.00011005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09059180.00011005</ArticleId></ArticleIdList></Reference><Reference><Citation>Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013(5):CD000165. 10.1002/14651858.CD000165.pub4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7064045</ArticleId><ArticleId IdType="pubmed">23728631</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride C, Emmons K, Lipkus I. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18(2):156&#x2013;170. doi: 10.1093/her/18.2.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/her/18.2.156</ArticleId><ArticleId IdType="pubmed">12729175</ArticleId></ArticleIdList></Reference><Reference><Citation>McCaul KD, Hockemeyer JR, Johnson RJ, et al. Motivation to quit using cigarettes: a review. Addict Behav. 2006;31:42&#x2013;56. doi: 10.1016/j.addbeh.2005.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addbeh.2005.04.004</ArticleId><ArticleId IdType="pubmed">15916861</ArticleId></ArticleIdList></Reference><Reference><Citation>Clair C, Mueller Y, Livingstone-Banks J, et al. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev. 2019;3:CD004705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6434771</ArticleId><ArticleId IdType="pubmed">30912847</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris J, Temple W. Spirometric, &#x201c;lung age&#x201d; estimation for motivating smoking cessation. Prev Med. 1985;14(5):655&#x2013;662. doi: 10.1016/0091-7435(85)90085-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0091-7435(85)90085-4</ArticleId><ArticleId IdType="pubmed">4070195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripoll J, Girauta H, Ramos M, et al. Clinical trial on the efficacy of exhaled carbon monoxide measurement in smoking cessation in primary health care. BMC Public Health. 2012;12:322. doi: 10.1186/1471-2458-12-322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-12-322</ArticleId><ArticleId IdType="pmc">PMC3390274</ArticleId><ArticleId IdType="pubmed">22551017</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkes G, Greenhalgh T, Griffin M, et al. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336(7644):598&#x2013;600. doi: 10.1136/bmj.39503.582396.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39503.582396.25</ArticleId><ArticleId IdType="pmc">PMC2267989</ArticleId><ArticleId IdType="pubmed">18326503</ArticleId></ArticleIdList></Reference><Reference><Citation>International Primary Care Respiratory Group. IPCRG teach the teacher funded by Global Bridges. 2016. https://www.ipcrg.org/projects/education/global-bridges/global-bridges-eastern-europe.</Citation></Reference><Reference><Citation>Gjorgjievski D, Ristovska R, Stavrikj K, et al. Effectiveness of combining feedback about lung age or exhaled carbon monoxide levels with very brief advice (VBA) and support for smoking cessation in primary care compared to giving VBA and support alone&#x2013;protocol for a randomized controlled trial withi. Open Access Maced J Med Sci. 2020;8(E):28&#x2013;36. doi: 10.3889/oamjms.2020.4519.</Citation><ArticleIdList><ArticleId IdType="doi">10.3889/oamjms.2020.4519</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Schayck OCP, Williams S, Barchilon V, et al. Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG. NPJ Prim Care Respir Med. 2017;27(1):38. doi: 10.1038/s41533-017-0039-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41533-017-0039-5</ArticleId><ArticleId IdType="pmc">PMC5466643</ArticleId><ArticleId IdType="pubmed">28600490</ArticleId></ArticleIdList></Reference><Reference><Citation>National Centre for Smoking Cessation and Training. Standard treatment programme. 2019. Available from: https://www.ncsct.co.uk/publication_ncsct-standard-treatment-programme.php.</Citation></Reference><Reference><Citation>Cooke F, Bullen C, Whittaker R, et al. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res. 2008;10(4):607&#x2013;612. doi: 10.1080/14622200801978680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14622200801978680</ArticleId><ArticleId IdType="pubmed">18418783</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P, Taylor R, Minor B, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi: 10.1016/j.jbi.2019.103208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)&#x2013;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377&#x2013;381. doi: 10.1016/j.jbi.2008.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotz D, Brown J, West R. Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking. Drug Alcohol Depend. 2013;128(1&#x2013;2):15&#x2013;19. doi: 10.1016/j.drugalcdep.2012.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2012.07.012</ArticleId><ArticleId IdType="pubmed">22943961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojedokun J, Keane S, O&#x2019;Connor K. Lung Age Bio-feedback Using a Portable Lung Age Meter with Brief Advice During Routine Consultations Promote Smoking Cessation &#x2013; Know2quit Multicenter Randomized Control Trial. J Gen Pract. 2013;1:123. 10.4172/2329-9126.1000123.</Citation></Reference><Reference><Citation>StataCorp . Stata statistical software: release 16. College Station: StataCorp LLC; 2019.</Citation></Reference><Reference><Citation>West R, Hajek P, Stead L, et al. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100(3):299&#x2013;303. doi: 10.1111/j.1360-0443.2004.00995.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1360-0443.2004.00995.x</ArticleId><ArticleId IdType="pubmed">15733243</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20(10):1727&#x2013;1736. doi: 10.1007/s11136-011-9903-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N, Janmohamed K, Jiang J, et al. Tobacco cessation in low- to middle-income countries: a scoping review of randomised controlled trials. Addict Behav. 2021;112:106612. doi: 10.1016/j.addbeh.2020.106612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addbeh.2020.106612</ArticleId><ArticleId IdType="pubmed">33002679</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickens A, et al. Using a rapid prioritisation process to identify health research priorities in LMICs. In: ERS Paris International Congress Primary care management of COPD theme. 2018.</Citation></Reference><Reference><Citation>Begh R, Lindson-Hawley N, Aveyard P. Does reduced smoking if you can&#x2019;t stop make any difference? BMC Med. 2015;13:257. doi: 10.1186/s12916-015-0505-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-015-0505-2</ArticleId><ArticleId IdType="pmc">PMC4601132</ArticleId><ArticleId IdType="pubmed">26456865</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond M, Astemborski J, Lambert A, et al. A randomized study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users. BMC Public Health. 2014;14:761. doi: 10.1186/1471-2458-14-761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-14-761</ArticleId><ArticleId IdType="pmc">PMC4132916</ArticleId><ArticleId IdType="pubmed">25074396</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation. WHO package of essential noncommunicable (pen) disease interventions for primary health care. 2020. https://www.who.int/publications/i/item/who-package-of-essential-noncommunicable-(pen)-disease-interventions-for-primary-health-care.</Citation></Reference><Reference><Citation>Akanbi M, Carroll A, Achenbach C, et al. The efficacy of smoking cessation interventions in low-and middle-income countries: a systematic review and meta-analysis. Addiction. 2019;114(4):620&#x2013;635. doi: 10.1111/add.14518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.14518</ArticleId><ArticleId IdType="pmc">PMC6411424</ArticleId><ArticleId IdType="pubmed">30506845</ArticleId></ArticleIdList></Reference><Reference><Citation>De Silva W, Awang R, Samsudeen S, et al. A randomised single-blinded controlled trial on the effectiveness of brief advice on smoking cessation among tertiary students in Malaysia. J Health Med Inform. 2016;7:217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828919</ArticleId><ArticleId IdType="pubmed">27081575</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PR, Zhao ZW, Cheng KK, et al. The effect of physician&#x2019;s 30 s smoking cessation intervention for male medical outpatients: a pilot randomized controlled trial. J Public Health (Oxf) 2013;35:375&#x2013;383. doi: 10.1093/pubmed/fdt018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdt018</ArticleId><ArticleId IdType="pubmed">23487178</ArticleId></ArticleIdList></Reference><Reference><Citation>Analytica. Survey on tobacco consumption in SEE countries North Macedonia. 2019. https://tobacconomics.org/files/research/574/National-study-Macedonia-1-1.pdf.</Citation></Reference><Reference><Citation>Hristovska Mijovic B, Spasova Mijovic T, Trpkova-Nestorovska M, et al. Tobacco farming and the effects of tobacco subsidies in North Macedonia, Analytica, Skopje, North Macedonia. 2022. https://tobacconomics.org/files/research/765/tobacco-farming-and-tobacco-subsidies-nmacedonia-final-layout.pdf.</Citation></Reference><Reference><Citation>Spasova T, Hristovska B. Accelerating progress on effective tobacco tax policies in low- and middle income countries National study - Macedonia. Tobacotaxation. 2018. https://tobacconomics.org/files/research/574/National-study-Macedonia-1-1.pdf.</Citation></Reference><Reference><Citation>Nikovska DG, Spasovski M, Gjorgjev D, et al. Social determinants of smoking in the population of the Republic of Macedonia - results from a nested case-control study. GJMEDPH. 2014;3(4):1&#x2013;8.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>